8-68015357-C-T

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_024870.4(PREX2):​c.142-2489C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.433 in 152,002 control chromosomes in the GnomAD database, including 17,389 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as association (no stars).

Frequency

Genomes: 𝑓 0.43 ( 17389 hom., cov: 33)

Consequence

PREX2
NM_024870.4 intron

Scores

2

Clinical Significance

association no assertion criteria provided O:1

Conservation

PhyloP100: -0.369

Publications

4 publications found
Variant links:
Genes affected
PREX2 (HGNC:22950): (phosphatidylinositol-3,4,5-trisphosphate dependent Rac exchange factor 2) The protein encoded by this gene belongs to the phosphatidylinositol 3,4,5-trisphosphate (PIP3)-dependent Rac exchanger (PREX) family, which are Dbl-type guanine-nucleotide exchange factors for Rac family small G proteins. Structural domains of this protein include the catalytic diffuse B-cell lymphoma homology and pleckstrin homology (DHPH) domain, two disheveled, EGL-10, and pleckstrin homology (DEP) domains, two PDZ domains, and a C-terminal inositol polyphosphate-4 phosphatase (IP4P) domain that is found in one of the isoforms. This protein facilitates the exchange of GDP for GTP on Rac1, allowing the GTP-bound Rac1 to activate downstream effectors. Studies also show that the pleckstrin homology domain of this protein interacts with the phosphatase and tensin homolog (PTEN) gene product to inhibit PTEN phosphatase activity, thus activating the phosphoinositide-3 kinase (PI3K) signaling pathway. Conversely, the PTEN gene product has also been shown to inhibit the GEF activity of this protein. This gene plays a role in insulin-signaling pathways, and either mutations or overexpression of this gene have been observed in some cancers. [provided by RefSeq, Apr 2016]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.66).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.744 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_024870.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PREX2
NM_024870.4
MANE Select
c.142-2489C>T
intron
N/ANP_079146.2
PREX2
NM_025170.6
c.142-2489C>T
intron
N/ANP_079446.3

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PREX2
ENST00000288368.5
TSL:1 MANE Select
c.142-2489C>T
intron
N/AENSP00000288368.4
PREX2
ENST00000529398.5
TSL:1
n.169-2489C>T
intron
N/A
PREX2
ENST00000854544.1
c.142-6679C>T
intron
N/AENSP00000524603.1

Frequencies

GnomAD3 genomes
AF:
0.433
AC:
65741
AN:
151884
Hom.:
17343
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.751
Gnomad AMI
AF:
0.439
Gnomad AMR
AF:
0.349
Gnomad ASJ
AF:
0.350
Gnomad EAS
AF:
0.185
Gnomad SAS
AF:
0.435
Gnomad FIN
AF:
0.280
Gnomad MID
AF:
0.361
Gnomad NFE
AF:
0.305
Gnomad OTH
AF:
0.414
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.433
AC:
65845
AN:
152002
Hom.:
17389
Cov.:
33
AF XY:
0.430
AC XY:
31981
AN XY:
74290
show subpopulations
African (AFR)
AF:
0.751
AC:
31186
AN:
41502
American (AMR)
AF:
0.349
AC:
5327
AN:
15270
Ashkenazi Jewish (ASJ)
AF:
0.350
AC:
1213
AN:
3466
East Asian (EAS)
AF:
0.185
AC:
955
AN:
5168
South Asian (SAS)
AF:
0.437
AC:
2102
AN:
4810
European-Finnish (FIN)
AF:
0.280
AC:
2952
AN:
10556
Middle Eastern (MID)
AF:
0.367
AC:
108
AN:
294
European-Non Finnish (NFE)
AF:
0.305
AC:
20723
AN:
67914
Other (OTH)
AF:
0.416
AC:
880
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
1628
3256
4885
6513
8141
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
568
1136
1704
2272
2840
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.337
Hom.:
38729
Bravo
AF:
0.449
Asia WGS
AF:
0.393
AC:
1365
AN:
3476

ClinVar

ClinVar submissions as Germline
Significance:association
Revision:no assertion criteria provided
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
-
Lip and oral cavity carcinoma (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.66
CADD
Benign
9.8
DANN
Benign
0.77
PhyloP100
-0.37
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs4512367; hg19: chr8-68927592; API